Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Review Article

Significance of and Challenges in Regulating Endocrine Disruptors – How Regulators and Industry Can Conquer?

Author(s): Sandeep Kumar Dhiman and Harish Dureja*

Volume 20, Issue 10, 2020

Page: [1664 - 1681] Pages: 18

DOI: 10.2174/1871530320666200606225104

Price: $65

Abstract

Endocrine disruptors (EDs) disrupt the standard operation of the endocrine systems, resulting in untoward effects. EDs have gained extensive consideration due to their severe adverse impacts on public and wildlife health. A variety of compounds from both natural and synthetic origin may cause endocrine disruptions. These may be found in industrial chemicals, persistent organic pollutants, and products of regular use including pharmaceuticals, medical equipment, implants, medical/surgical and dental devices, cosmetics, food products, other consumer goods, their packaging and processing materials. Apart from direct consumption or use, these chemicals may impact by entering our food chain or ecosystem. These chemicals act by mimicking the hormones or blocking their receptors or interfering in their normal production, absorption, distribution, metabolism and excretion. The implementation of a regulatory framework on the complex multidisciplinary field of EDs brings enormous challenges, which pose barriers to the regulatory process. This study aims to focus on the key public and ecological health concerns presented by EDs, challenges faced by regulators to achieve successful regulatory proposition and the importance of collaboration endeavours to potentially conquer such challenges. Endocrine-disrupting chemicals (EDCs) or EDs can impact at low exposure levels, bringing about a broad range of health issues including disorders related to reproductive, fetal development, neurological, immunological, metabolic and cancer, etc. They may cause health effects across generations. The regulatory frameworks available across major regulators are tackling the identification of EDs and their mechanisms to provide necessary guidance on the safety and disposal of such substances. However, the challenges faced outweigh the regulatory mechanisms in place. The major challenges are related to structural ranges at times leading to no representative structures, active metabolites, substantiate quantum, delayed effects, epigenetic changes, widespread existence, concentration correlation for different biological species, availability of appropriate methods, exposure to a mixture of chemicals, complex endocrinology principles, unknown sources, routes and mechanisms, impacts at early stages of life, geographical movement of EDs, hazard-based vs. risk-based approaches. Regulators of healthcare and environmentalists needs to collaborate amongst them and with wider stakeholders including industry sponsors to find ways of dealing with such challenges and capitalize on the research-based knowledge grid available across institutions. Existence of EDs, their impact on living beings and mechanism of influence are like a tangled web, which induces difficulties in regulating them with conventional mindset. Conquering these challenges necessitates that regulators should join forces amongst themselves, with other institutions operating for environment, with industry sponsors and researchers to achieve success in public health safety.

Keywords: Endocrine disruptors, EDs, EDCs, hormones, collaboration, challenges, public health, identification, testing.

Graphical Abstract
[1]
Endocrine Disruptor Knowledge Base. 2019. Available at: https://www.fda.gov/science-research/bioinformatics-tools/endocrine-disruptor-knowledge-base (Accessed on June 21, 2019).
[2]
Endocrine Disruptors., 2019. Available at: https://www.niehs.nih.gov/health/topics/agents/endocrine/index.cfm (Accessed on June 16, 2019).
[3]
Endocrine Disrupting Chemicals (EDCs).. , 2013. Available at: https://www.who.int/ceh/risks/cehemerging2/en/ (Accessed on June 16, 2019).
[4]
Endocrine disruptors, 2010. Available at: https://www.niehs.nih.gov/health/materials/endocrine_disruptors_508.pdf (Accessed on June 16, 2019).
[5]
State of the science of endocrine disrupting chemicals – 2012: An assessment of the state of the science of endocrine disruptors prepared by a group of experts for the United Nations Environment Programme (UNEP) and WHO., 2013. Available at: https://www.who.int/ceh/publications/endocrine/en/ (Accessed on June 21, 2019).
[6]
Endocrine Disruptors Research. 2018. Available at: https://www.niehs.nih.gov/research/programs/endocrine/index.cfm (Accessed on June 16, 2019).
[7]
Nonclinical Evaluation of Endocrine-Related Drug Toxicity - Guidance for Industry. 2015. Available at: https://www.fda.gov/media/86996/download (Accessed on May 20, 2019).
[8]
Sabir, S.; Akhtar, M.F.; Saleem, A. Endocrine disruption as an adverse effect of non-endocrine targeting pharmaceuticals. Environ. Sci. Pollut. Res. Int., 2019, 26(2), 1277-1286.
[http://dx.doi.org/10.1007/s11356-018-3774-4] [PMID: 30467752]
[9]
Monneret, C. What is an endocrine disruptor? C. R. Biol., 2017, 340(9-10), 403-405.
[http://dx.doi.org/10.1016/j.crvi.2017.07.004] [PMID: 29126512]
[10]
Effect of pharmaceutical potential endocrine disruptor compounds on protein disulfide isomerase reductase activity using di-eosin-oxidizedglutathion., 2010. Available at: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009507 (Accessed on May 18, 2019).
[11]
Endocrine disruptor, 2019. (Accessed on 2019 May 18); Available at: https://en.wikipedia.org/wiki/Endocrine_disruptor
[12]
There are nearly 1,000 chemicals in our food that have never been tested for safety, 2018. Available at: https://www.vice.com/en_us/article/a38gxk/there-are-nearly-1000-chemicals-in-our-food-that-have-never-been-tested-for-safety (Accessed on June 16, 2019).
[13]
Is BPA safe? Endocrine society addresses FDA position on commercial BPA use, 2018. Available at: https://www.endocrinologyadvisor.com/home/topics/general-endocrinology/is-bpa-safe-endocrine-society-addresses-fda-position-on-commercial-bpa-use/ (Accessed on July 20, 2019).
[14]
Facts about BPA: Medical., 2019. Available at: https://www.factsaboutbpa.org/benefits-applications/medical (Accessed on July 20, 2019).
[15]
Facts about BPA: Why BPA?, 2014. Available at: https://www.factsaboutbpa.org/benefits-applications/why-bpa (Accessed on June 16, 2019).
[16]
BPA (Besophenol A). 2019. (Accessed on 2019 July 20); Available at: https://www.chemicalsafetyfacts.org/bpa-bisphenol-a/
[17]
Endocrine disruptors: Estrogens in a bottle?, 2009. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702426/ (Accessed on May 18, 2019).
[18]
Endocrine disruptors, 2019. Available at: http://web.colby.edu/cleanmakeup/meet-the-ingredients/endocrine-disruptors/ (Accessed on July 20, 2019).
[19]
Bisphenol, A. (BPA): Use in food contact application; , 2018. Available at: https://www.fda.gov/food/food-additives-petitions/bisphenol-bpa-use-food-contact-application (Accessed on June 15, 2019).
[20]
Bisphenol A and related compounds in dental materials, 2010. Available at: https://pediatrics.aappublications.org/content/126/4/760 (Accessed on June 20, 2019).
[21]
Naturally occurring endocrine active substances (Q&A), 2014. Available at: https://www.eufic.org/en/food-safety/article/naturally-occurring-endocrine-active-substances-qa (Accessed on June 16, 2019).
[22]
Licorice., 2018. Available at: https://www.drugs.com/npp/licorice.html (Accessed on July 28, 2019).
[23]
Dhiman, S.K.; Dureja, H.; Gummadi, V. Partnership efforts – Their potential to reduce the challenges that confront regulators and pharmaceutical industry. Appl. Clin. Res. Clin. Trials Regul. Aff., 2019, 6(1), 7-17.
[http://dx.doi.org/10.2174/2213476X06999190206120109]
[24]
Schug, T.T.; Johnson, A.F.; Birnbaum, L.S.; Colborn, T.; Guillette, L.J., Jr; Crews, D.P.; Collins, T.; Soto, A.M.; Vom Saal, F.S.; McLachlan, J.A.; Sonnenschein, C.; Heindel, J.J. Minireview: Endocrine Disruptors: Past Lessons and Future Directions. Mol. Endocrinol., 2016, 30(8), 833-847.
[http://dx.doi.org/10.1210/me.2016-1096] [PMID: 27477640]
[25]
Endocrine disruptors: Regulatory requirements, implications, and options, 2015. Available at: https://www.productstewards.org/Resources/Documents/Endocrine-Disruptors-Jane-Stavely.pdf (Accessed on July 20, 2019).
[26]
Endocrine disruptor regulations and lists in USA., 2019. Available at: https://www.chemsafetypro.com/Topics/USA/Endocrine_Disruptor_Regulations_and_Lists_in_USA.html (Accessed on July 20, 2019).
[27]
Endocrine disruptor screening program (EDSP) overview, 2019. Available at: https://www.epa.gov/endocrine-disruption/endocrine-disruptor-screening-program-edsp-overview (Accessed on July 20, 2019).
[28]
EDKB Resources, 2018. Available at: https://www.fda.gov/science-research/endocrine-disruptor-knowledge-base/edkb-resources (Accessed on June 21, 2019).
[29]
Endocrine Disruptor Knowledge Base. 2019. Available at: https://www.fda.gov/science-research/bioinformatics-tools/endocrine-disruptor-knowledge-base (Accessed on June 21, 2019).
[30]
Endocrine Disruptors., 2019. Available at: https://ec.europa.eu/environment/chemicals/endocrine/index_en.htm (Accessed on June 15, 2019).
[31]
Process to set scientific criteria to identify endocrine disruptors, 2018. (Accessed on 2019 July 20); Available at: https://ec.europa.eu/health/endocrine_disruptors/process_en
[32]
Endocrine active substances., 2018. Available at: https://www.efsa.europa.eu/en/topics/topic/endocrine-active-substances (Accessed on July 20, 2019).
[33]
Endocrine disruptors, 2018. Available at: https://ec.europa.eu/health/endocrine_disruptors/overview_en (Accessed on July 20, 2019).
[34]
Conference "Endocrine disruptors: criteria for identification and related impacts", 2015. Available at: https://ec.europa.eu/health/endocrine_disruptors/events/ev_20150416_en (Accessed on July 20, 2019).
[35]
Endocrine Disruptors Strategy. 2019. Available at: https://ec.europa.eu/environment/chemicals/endocrine/strategy/index_en.htm (Accessed on June 16, 2019).
[36]
Scientific Opinion on the hazard assessment of endocrine disruptors: Scientific criteria for identification of endocrine disruptors and appropriateness of existing test methods for assessing effects mediated by these substances on human health and the environment, 2013. Available at: https://efsa.onlinelibrary.wiley.com/doi/abs/10.2903/j.efsa.2013.3132 (Accessed on June 16, 2019).
[37]
Marx-Stoelting, P.; Niemann, L.; Ritz, V.; Ulbrich, B.; Gall, A.; Hirsch-Ernst, K.I.; Pfeil, R.; Solecki, R. Assessment of three approaches for regulatory decision making on pesticides with endocrine disrupting properties. Regul. Toxicol. Pharmacol., 2014, 70(3), 590-604.
[http://dx.doi.org/10.1016/j.yrtph.2014.09.001] [PMID: 25239592]
[38]
Bars, R.; Fegert, I.; Gross, M.; Lewis, D.; Weltje, L.; Weyers, A.; Wheeler, J.R.; Galay-Burgos, M. Risk assessment of endocrine active chemicals: identifying chemicals of regulatory concern. Regul. Toxicol. Pharmacol., 2012, 64(1), 143-154.
[http://dx.doi.org/10.1016/j.yrtph.2012.06.013] [PMID: 22735369]
[39]
Gross, M.; Green, R.M.; Weltje, L.; Wheeler, J.R. Weight of evidence approaches for the identification of endocrine disrupting properties of chemicals: Review and recommendations for EU regulatory application. Regul. Toxicol. Pharmacol., 2017, 91, 20-28.
[http://dx.doi.org/10.1016/j.yrtph.2017.10.004] [PMID: 28986177]
[40]
Day, P.; Green, R.M.; Gross, M.; Weltje, L.; Wheeler, J.R. Endocrine Disruption: Current approaches for regulatory testing and assessment of plant protection products are fit for purpose. Toxicol. Lett., 2018, 296, 10-22.
[http://dx.doi.org/10.1016/j.toxlet.2018.07.011] [PMID: 30006252]
[41]
Regulating Endocrine Disrupting Chemicals in Consumer Products. 2016. Available at: https://www.alpco.com/regulating-endocrine-disrupting-chemicals-consumer-products (Accessed on June 21, 2019).
[42]
Vandenberg, L.N.; Colborn, T.; Hayes, T.B.; Heindel, J.J.; Jacobs, D.R., Jr; Lee, D.H.; Myers, J.P.; Shioda, T.; Soto, A.M.; vom Saal, F.S.; Welshons, W.V.; Zoeller, R.T. Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. Reprod. Toxicol., 2013, 38, 1-15.
[http://dx.doi.org/10.1016/j.reprotox.2013.02.002] [PMID: 23411111]
[43]
Health threats from endocrine disruptors: A scientific and regulatory challenge., 2012. Available at: http://www.europarl.europa.eu/RegData/bibliotheque/briefing/2012/120303/LDM_BRI(2012)120303_REV1_EN.pdf (Accessed on July 20, 2019).
[44]
Leopold, A.; Kraak, G.V.D.; Manibusan, M.; Andersson, N.; Wheeler, J.R. Introduction to the science and regulation concerning endocrine disrupting chemicals: challenges ahead. PeerJ. Preprints, 2016, 4e2583v1
[45]
US National Library of Medicine – ClinicalTrials. gov: Endocrine Disruptors. 2019. Available at: ClinicalTrials.gov listing of NIEHS Endocrine Disruptors studies, 2019. (Accessed on July 20, 2019)
[46]
Endocrine disruptors: solutions to new challenges, 2012. Available at: http://istas.net/descargas/disruptores_endocrinos-eng.pdf (Accessed on June 16, 2019).
[47]
NC researchers circle on chemicals that disrupt hormones., 2019. Available at: https://factor.niehs.nih.gov/2019/5/science-highlights/edc-nc/index.htm (Accessed on July 20, 2019).
[48]
Effects of human exposure to hormone-disrupting chemicals examined in landmark UN report., 2013. Available at: https://www.who.int/mediacentre/news/releases/2013/hormone_disrupting_20130219/en/ (Accessed on June 16, 2019).
[49]
Lamb, J.C., IV; Boffetta, P.; Foster, W.G.; Goodman, J.E.; Hentz, K.L.; Rhomberg, L.R.; Staveley, J.; Swaen, G.; Van Der Kraak, G.; Williams, A.L. Critical comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals - 2012. Regul. Toxicol. Pharmacol., 2014, 69(1), 22-40.
[http://dx.doi.org/10.1016/j.yrtph.2014.02.002] [PMID: 24530840]
[50]
Endocrine society experts express concern with FDA statement on BPA safety., 2018. Available at: https://www.endocrine.org/news-room/2018/endocrine-society-experts-express-concern-with-fda-statement-on-bpa-safety (Accessed on July 20, 2019).
[51]
First annual forum on endocrine disruptors., 2019. Available at: https://ec.europa.eu/environment/chemicals/reach/events_en.htm (Accessed on November 8, 2019).

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy